Ipilimumab (Yervoy) for Metastatic Melanoma

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2011年 / 53卷 / 1367期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [41] Severe colitis while responding to ipilimumab in metastatic melanoma
    Slingerland, Marije
    Nortier, Johan W. R.
    Veenendaal, Roeland A.
    Kapiteijn, Ellen
    ACTA ONCOLOGICA, 2012, 51 (06) : 805 - U135
  • [42] STUDY OF A COHORT OF PATIENTS WITH METASTATIC MELANOMA TREATED WITH IPILIMUMAB
    Roussel, A.
    Berthe, A.
    Quereux, G.
    Dreno, B. R. I.
    Thomare, P.
    ANNALS OF ONCOLOGY, 2013, 24 : 36 - 36
  • [43] Predictive biomarkers of ipilimumab toxicity in metastatic melanoma.
    Gowen, Michael
    Tchack, Jeremy
    Zhou, Hua
    Giles, Keith Michael
    Paschke, Scott
    Moran, Una
    Fenyo, David
    Tsirigos, Aristotelis
    Pacold, Michael
    Pavlick, Anna C.
    Krogsgaard, Michelle
    Osman, Iman
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] A response to the ipilimumab treatment of a patient with a diagnosis of metastatic melanoma
    Pekala, Anika
    Ulanska, Malgorzata
    Blasinska-Morawiec, Maria
    ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 : H1 - H6
  • [45] Acute autoimmune hepatitis secondary to ipilimumab in metastatic melanoma
    Laidler, N.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 66 - 67
  • [46] Panhypopituitarism in metastatic melanoma patient treated with ipilimumab and pembrolizumab
    Goto, Haruka
    Kasuya, Akira
    Imura, Kie
    Miyazawa, Hidehiko
    Fujiyama, Toshiharu
    Kakizawa, Keisuke
    Tokura, Yoshiki
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2019, 2 (02) : 60 - 61
  • [47] Ipilimumab in the treatment of metastatic melanoma: management of adverse events
    Scarpati, Giuseppina Della Vittoria
    Fusciello, Celeste
    Perri, Francesco
    Sabbatino, Francesco
    Ferrone, Soldano
    Carlomagno, Chiara
    Pepe, Stefano
    ONCOTARGETS AND THERAPY, 2014, 7 : 203 - 209
  • [48] Ipilimumab efficacy and safety profile in metastatic melanoma in Saskatchewan
    Papneja, N.
    Olson, C.
    Lee, C. H.
    Lim, H.
    Bryce, R.
    Gesy, K.
    Iqbal, N.
    Abbas, T.
    ANNALS OF ONCOLOGY, 2016, 27
  • [49] Ipilimumab in the treatment of metastatic melanoma: a summary of recent studies
    Ascierto, Paolo A.
    TUMORI, 2013, 99 (06) : E302 - E305
  • [50] Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma
    Adler, N. R.
    Murray, W. K.
    Brady, B.
    McCormack, C.
    Pan, Y.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (04) : 497 - 499
12345